NDC properties for "tetracycline hydrochloride 250 MG Oral Capsule" (RxCUI 198250)
About this data
The tables show NDC propoerties for tetracycline hydrochloride 250 MG Oral Capsule with the RxCUI 198250
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline hydrochloride 250 MG Oral Capsule (RxCUI 198250)
ANDA | ANDA060704 |
---|---|
ANDA | ANDA061837 |
ANDA | ANDA062752 |
ANDA | ANDA210662 |
ANDA | ANDA210674 |
ANDA | ANDA212635 |
MMSL_CODE | BD3024 |
NDA | NDA050278 |
RxCUI | 198250 |
SNOMEDCT | 374237001 |
SPL_SET_ID | 00acf413-c5d2-4a54-9d0d-56266cbc9edc |
SPL_SET_ID | 2854d3b7-f874-4c67-8014-adda9639f515 |
SPL_SET_ID | 32a409a0-fea6-411a-8218-c1c7df46d664 |
SPL_SET_ID | 3ce3e8dc-7fbd-4f8d-a65f-092e1ef21725 |
SPL_SET_ID | 5419f5dd-bf20-4eea-982d-33511a022c38 |
SPL_SET_ID | 6f363d06-2400-43be-8fe5-69246c0fdc49 |
SPL_SET_ID | aa30113f-ab58-4f41-82c1-2fcb540d4a82 |
SPL_SET_ID | ae29aa18-6efb-47c9-bbd7-cbe8af1b7f38 |
SPL_SET_ID | b45cee2a-8d11-4fda-b8f8-e1f71abf87c6 |
SPL_SET_ID | b504e612-5aef-47fa-8f7b-dfb754011b9f |
SPL_SET_ID | eaa5b1bd-0927-46e4-b941-32fcc492d258 |
SPL_SET_ID | fb338af1-2b1b-413f-9653-10f318dbc4b3 |
VUID | 4001908 |
Prescribable Synonym | tetracycline HCl 250 MG Oral Capsule |
RXNAV_STR | tetracycline hydrochloride 250 MG Oral Capsule |
RxNorm Name | tetracycline hydrochloride 250 MG Oral Capsule |
Related queries | Interactions (for RxCUI 198250) |
NDC Properties
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |
NDC Item 00440250528
NDC 9 | 0440-2505 |
---|---|
NDC 10 | 0440-2505-28 |
NDC Item | 00440250528 |
Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
NDC 9 | 0591-2474 |
---|---|
NDC 10 | 0591-2474-01 |
NDC Item | 00591247401 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
ANDA | ANDA061837 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2234 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00917080901 |
Related queries | Properties for NDC 9 |
NDC Item 23155001701
NDC 9 | 23155-017 |
---|---|
NDC 10 | 23155-017-01 |
NDC Item | 23155001701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;17 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
NDC 9 | 23155-766 |
---|---|
NDC 10 | 23155-766-01 |
NDC Item | 23155076601 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5225 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
NDC 9 | 47781-508 |
---|---|
NDC 10 | 47781-508-01 |
NDC Item | 47781050801 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
Color | C48330;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5225 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-07-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-01 |
NDC Item | 51991090601 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-05 |
NDC Item | 51991090605 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
NDC 9 | 51991-906 |
---|---|
NDC 10 | 51991-906-33 |
NDC Item | 51991090633 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE,YELLOW |
Color | C48333;C48330 __ |
FDA SPL set id | 777555 |
Imprint code | B906 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-00 |
NDC Item | 52959028300 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-12 |
NDC Item | 52959028312 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-20 |
NDC Item | 52959028320 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-28 |
NDC Item | 52959028328 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-30 |
NDC Item | 52959028330 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
NDC 9 | 52959-283 |
---|---|
NDC 10 | 52959-283-40 |
NDC Item | 52959028340 |
Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
NDC 9 | 60219-1522 |
---|---|
NDC 10 | 60219-1522-1 |
NDC Item | 60219152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-01 |
NDC Item | 62135022501 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-05 |
NDC Item | 62135022505 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-20 |
NDC Item | 62135022520 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
NDC 9 | 62135-225 |
---|---|
NDC 10 | 62135-225-60 |
NDC Item | 62135022560 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
ANDA | ANDA062752 |
COLORTEXT | yellow |
Color | C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5225 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
NDC 9 | 64380-890 |
---|---|
NDC 10 | 64380-890-06 |
NDC Item | 64380089006 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;01 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-12 |
NDC Item | 66267020012 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-28 |
NDC Item | 66267020028 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
NDC 9 | 66267-200 |
---|---|
NDC 10 | 66267-200-40 |
NDC Item | 66267020040 |
Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
NDC 9 | 67405-660 |
---|---|
NDC 10 | 67405-660-10 |
NDC Item | 67405066010 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
ANDA | ANDA062752 |
COLORTEXT | YELLOW |
Color | C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5225 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-02-28 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 19 mm |
Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
NDC 9 | 69238-1522 |
---|---|
NDC 10 | 69238-1522-1 |
NDC Item | 69238152201 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1522 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
Related queries | Properties for NDC 9 69238-1522 |